Ardent Health (ARDT) Financials: Revenue & Earnings
ARDT$12.22+0.29 +2.47%
$1.72B
Market Cap
22.31
P/E
12.80
Forward P/E
44
Score
Ardent Health (ARDT) Financials: Revenue & Earnings
ARDT price $12.22 +0.29 +2.47%
- Ticker
- ARDT
- Price
- $12.22
- Change
- +0.29 +2.47%
- Market cap ?
- $1.72B
- P/E ?
- 22.31
- Forward P/E ?
- 12.80
- Dividend yield ?
- 0.00%
- Beta ?
- 0.72
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Stocklytics score
- 44
- Value
- 77
- Quality
- 38
- Growth
- 18
Stocklytics score rationale: value 77, quality 38, growth 18.
Financials
| 2015 | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 2029372000 | 2105216000 | 3002076000 | 4161875000 | 4870396000 | 5129687000 | 5409483000 | 5966072000 | 6324339000 |
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory…
Fair value
ARDT fair value $13.92. Price $12.22. Price is 12% below fair value.
Above fair value, and more expensive than usual. A larger premium than on 98% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 156.80M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 141.05M. Net debt 1.55B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 0.23 | — | 1.60B |
| 2026-08-04 | 0.12 | 0.18 | 1.62B | 1.59B |
| 2026-05-05 | 0.28 | 0.18 | 1.60B | 1.58B |
| 2026-03-04 | 0.32 | 0.35 | 1.61B | 1.63B |
| 2025-11-12 | 0.52 | 0.42 | 1.58B | 1.55B |
| 2025-08-05 | 0.52 | 0.30 | 1.65B | 1.63B |
| 2025-05-06 | 0.29 | 0.21 | 1.50B | 1.50B |
| 2025-02-26 | 0.81 | 0.50 | 1.61B | 1.50B |
| 2024-11-06 | 0.17 | 0.30 | 1.45B | 1.45B |
| 2024-08-14 | 0.34 | 0.30 | 1.47B | 1.46B |
| 2024-06-21 | 0.21 | — | 1.44B | — |
| 2023-12-31 | -0.05 | — | 1.35B | — |
| 2023-09-30 | 0.15 | — | 1.38B | — |
| 2023-06-30 | 0.23 | — | 1.37B | — |
| 2023-03-31 | 0.03 | — | 1.32B | — |
| 2018-12-30 | -0.15 | — | 1.09B | — |
| 2018-09-30 | 0.04 | — | 1.09B | — |
| 2018-06-30 | -0.10 | — | 989.88M | — |
| 2018-03-31 | -0.10 | — | 989.88M | — |
| 2017-03-31 | 0.03 | — | 685.11M | — |
| 2015-06-30 | 0.12 | — | 505.31M | — |
| 2015-03-31 | 0.12 | — | 505.31M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-25 | LUMSDAINE ALFRED | Sell | 3.39K | $10.54 | 35.72K |
| 2026-09-25 | Petrovich Stephen C. | Sell | 788 | $10.54 | 8.31K |
| 2026-09-25 | Byers David Raynor | Sell | 524 | $10.54 | 5.52K |
| 2026-07-01 | Caspers Dave | Buy | 103.65K | — | — |
| 2026-06-05 | DeMichiei Robert | Buy | 11.26K | $8.73 | 98.30K |
| 2026-06-05 | LUMSDAINE ALFRED | Buy | 10.00K | $8.81 | 88.10K |
| 2026-04-01 | Bulgarelli Peter J. | Buy | 14.23K | — | — |
| 2026-04-01 | Havdala Ellen | Buy | 14.23K | — | — |
| 2026-04-01 | Sotir Mark R | Buy | 14.23K | — | — |
| 2026-04-01 | Sen Rahul | Buy | 14.23K | — | — |
| 2026-04-01 | Webb Robert Thomas | Buy | 14.23K | — | — |
| 2026-04-01 | Robinson Edmondo | Buy | 14.23K | — | — |
| 2026-04-01 | DeMichiei Robert | Buy | 14.23K | — | — |
| 2026-04-01 | GOODYEAR WILLIAM M | Buy | 14.23K | — | — |
| 2026-04-01 | Campion Suzanne | Buy | 14.23K | — | — |
| 2026-04-01 | BYNOE PETER C B | Buy | 14.23K | — | — |
| 2026-04-01 | Caspers Dave | Buy | 35.67K | — | — |
| 2026-04-01 | Caspers Dave | Sell | 2.68K | $8.67 | 23.27K |
| 2026-04-01 | Petrovich Stephen C. | Buy | 24.90K | — | — |
| 2026-04-01 | Petrovich Stephen C. | Sell | 1.81K | $8.67 | 15.68K |
| 2026-04-01 | Byers David Raynor | Buy | 11.54K | — | — |
| 2026-04-01 | Byers David Raynor | Sell | 924 | $8.67 | 8.01K |
| 2026-04-01 | LUMSDAINE ALFRED | Buy | 53.85K | — | — |
| 2026-04-01 | LUMSDAINE ALFRED | Sell | 4.38K | $8.67 | 37.98K |
| 2026-04-01 | Bonick Martin | Buy | 134.62K | — | — |
| 2026-04-01 | Bonick Martin | Sell | 10.95K | $8.67 | 94.95K |
| 2026-03-31 | Petrovich Stephen C. | Sell | 1.43K | $8.56 | 12.20K |
| 2026-03-31 | Byers David Raynor | Sell | 819 | $8.56 | 7.01K |
| 2026-03-31 | LUMSDAINE ALFRED | Sell | 2.51K | $8.56 | 21.49K |
| 2026-03-31 | Bonick Martin | Sell | 8.03K | $8.56 | 68.70K |
| 2026-03-11 | Petrovich Stephen C. | Buy | 34.73K | — | — |
| 2026-03-11 | LUMSDAINE ALFRED | Buy | 61.08K | — | — |
| 2026-03-11 | Chernin Ethan | Buy | 32.41K | — | — |
| 2026-03-11 | Bonick Martin | Buy | 195.32K | — | — |
| 2026-03-11 | Byers David Raynor | Buy | 8.86K | — | — |
| 2025-09-25 | LUMSDAINE ALFRED | Sell | 3.39K | $13.19 | 44.70K |
| 2025-09-25 | Petrovich Stephen C. | Sell | 788 | $13.19 | 10.39K |
| 2025-09-25 | Byers David Raynor | Sell | 524 | $13.19 | 6.91K |
| 2025-04-02 | DeMichiei Robert | Buy | 10.07K | — | — |
| 2025-04-02 | DeMichiei Robert | Other | 0 | — | — |
| 2025-04-01 | Caspers Dave | Buy | 33.06K | — | — |
| 2025-04-01 | Caspers Dave | Buy | 7.71K | — | — |
| 2025-04-01 | Caspers Dave | Sell | 2.48K | $12.97 | 32.17K |
| 2025-04-01 | Byers David Raynor | Buy | 11.56K | — | — |
| 2025-04-01 | Chernin Ethan | Buy | 20.91K | — | — |
| 2025-04-01 | Schultz David | Buy | 26.98K | — | — |
| 2025-04-01 | Petrovich Stephen C. | Buy | 22.26K | — | — |
| 2025-04-01 | LUMSDAINE ALFRED | Buy | 53.97K | — | — |
| 2025-04-01 | Bonick Martin | Buy | 134.93K | — | — |
| 2025-03-31 | Caspers Dave | Other | 0 | — | — |
| 2025-03-31 | Byers David Raynor | Sell | 676 | $13.75 | 9.29K |
| 2025-03-31 | Chernin Ethan | Sell | 1.33K | $13.75 | 18.32K |
| 2025-03-31 | Schultz David | Sell | 1.82K | $13.75 | 25.09K |
| 2025-03-31 | Petrovich Stephen C. | Sell | 1.43K | $13.75 | 19.64K |
| 2025-03-31 | LUMSDAINE ALFRED | Sell | 2.51K | $13.75 | 34.51K |
| 2025-03-31 | Bonick Martin | Sell | 12.97K | $13.75 | 178.34K |
| 2025-03-21 | Campion Suzanne | Buy | 12.92K | — | — |
| 2025-03-21 | BYNOE PETER C B | Buy | 12.92K | — | — |
| 2025-03-21 | GOODYEAR WILLIAM M | Buy | 12.92K | — | — |
| 2025-03-21 | Havdala Ellen | Buy | 12.92K | — | — |
| 2025-03-21 | Sen Rahul | Buy | 12.92K | — | — |
| 2025-03-21 | Sotir Mark R | Buy | 12.92K | — | — |
| 2025-03-21 | Robinson Edmondo | Buy | 12.92K | — | — |
| 2025-03-21 | Webb Robert Thomas | Buy | 12.92K | — | — |
| 2024-12-12 | Webb Robert Thomas | Buy | 10.79K | — | — |
| 2024-12-12 | Robinson Edmondo | Buy | 10.79K | — | — |
| 2024-12-12 | Havdala Ellen | Buy | 10.79K | — | — |
| 2024-12-12 | BYNOE PETER C B | Buy | 10.79K | — | — |
| 2024-12-12 | Campion Suzanne | Buy | 10.79K | — | — |
| 2024-12-12 | GOODYEAR WILLIAM M | Buy | 10.79K | — | — |
| 2024-11-08 | Webb Robert Thomas | Buy | 10.00K | $16.49 | 164.90K |
| 2024-11-08 | Webb Robert Thomas | Buy | 10.00K | $17.47 | 174.70K |
| 2024-09-25 | Petrovich Stephen C. | Buy | 9.70K | — | — |
| 2024-09-25 | LUMSDAINE ALFRED | Buy | 41.74K | — | — |
| 2024-09-25 | Schultz David | Buy | 16.54K | — | — |
| 2024-09-25 | Byers David Raynor | Buy | 6.45K | — | — |
| 2024-07-18 | Petrovich Stephen C. | Buy | 17.58K | — | — |
| 2024-07-18 | Webb Robert Thomas | Buy | 11.56K | — | — |
| 2024-07-18 | Sotir Mark R | Buy | 11.56K | — | — |
| 2024-07-18 | Sen Rahul | Buy | 11.56K | — | — |
| 2024-07-18 | Robinson Edmondo | Buy | 11.56K | — | — |
| 2024-07-18 | Havdala Ellen | Buy | 11.56K | — | — |
| 2024-07-18 | GOODYEAR WILLIAM M | Buy | 11.56K | — | — |
| 2024-07-18 | Campion Suzanne | Buy | 11.56K | — | — |
| 2024-07-18 | BYNOE PETER C B | Buy | 11.56K | — | — |
| 2024-07-18 | Schultz David | Buy | 22.48K | — | — |
| 2024-07-18 | LUMSDAINE ALFRED | Buy | 30.92K | — | — |
| 2024-07-18 | Chernin Ethan | Buy | 16.41K | — | — |
| 2024-07-18 | Byers David Raynor | Buy | 8.33K | — | — |
| 2024-07-18 | Bonick Martin | Buy | 98.88K | — | — |
| 2024-07-17 | Pure Health Capital Americas 1 SPV RSC LTD | Other | 0 | — | — |
| 2024-07-17 | Petrovich Stephen C. | Other | 0 | — | — |
| 2024-07-17 | Petrovich Stephen C. | Other | 0 | — | — |
| 2024-07-17 | BYNOE PETER C B | Other | 0 | — | — |
| 2024-07-17 | Byers David Raynor | Other | 0 | — | — |
| 2024-07-17 | LUMSDAINE ALFRED | Other | 0 | — | — |
| 2024-07-17 | Schultz David | Other | 0 | — | — |
| 2024-07-17 | Bonick Martin | Other | 0 | — | — |
| 2024-07-17 | Campion Suzanne | Other | 0 | — | — |
| 2024-07-17 | GOODYEAR WILLIAM M | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 142, holders +5 vs prior quarter. Ownership 76.69%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CHAI TRUST CO LLC | 77.25M | 0 | 0.00% | 760.11M |
| VENTAS, INC. | 9.34M | 0 | 0.00% | 91.93M |
| BLACKROCK, INC. | 2.18M | 418.13K | +23.78% | 21.42M |
| AMERIPRISE FINANCIAL INC | 2.11M | 333.87K | +18.79% | 20.77M |
| GOLDENTREE ASSET MANAGEMENT LP | 1.58M | -722.69K | -31.38% | 15.53M |
| AQR CAPITAL MANAGEMENT LLC | 1.45M | 505.46K | +53.64% | 14.25M |
| CASTLEKNIGHT MANAGEMENT LP | 1.08M | 0 | 0.00% | 10.60M |
| VANGUARD CAPITAL MANAGEMENT LLC | 963.83K | -44.60K | -4.42% | 9.48M |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 841.13K | -89.54K | -9.62% | 8.28M |
| GEODE CAPITAL MANAGEMENT, LLC | 620.95K | 59.50K | +10.60% | 6.11M |
| ALGERT GLOBAL LLC | 597.75K | 554.35K | +1277.29% | 5.88M |
| STATE STREET CORP | 566.21K | -19.85K | -3.39% | 5.57M |
| FIRST TRUST ADVISORS LP | 562.28K | 83.48K | +17.44% | 5.53M |
| EMPOWERED FUNDS, LLC | 551.29K | 15.46K | +2.88% | 5.42M |
| SAGEVIEW ADVISORY GROUP, LLC | 480.45K | -160.15K | -25.00% | 4.73M |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 444.90K | 2.30K | +0.52% | 4.38M |
| UBS GROUP AG | 442.62K | -8.06K | -1.79% | 4.36M |
| BANK OF AMERICA CORP /DE/ | 390.24K | 29.20K | +8.09% | 3.84M |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 327.24K | 222.45K | +212.27% | 3.22M |
| MORGAN STANLEY | 315.96K | 23.93K | +8.19% | 3.11M |
| AMERICAN CENTURY COMPANIES INC | 309.36K | 254.17K | +460.51% | 3.04M |
| GOLDMAN SACHS GROUP INC | 304.45K | 85.44K | +39.01% | 3.00M |
| JANE STREET GROUP, LLC | 300.34K | 106.32K | +54.80% | 2.96M |
| JPMORGAN CHASE & CO | 242.33K | 73.72K | +43.72% | 2.41M |
| BANK OF NEW YORK MELLON CORP | 241.59K | 535 | +0.22% | 2.38M |
Earnings and financials
Ardent Health Inc. (ARDT) trades at $12.22, with a market cap of $1.72B and a trailing P/E of 22.31. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2015 | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 2029372000 | 2105216000 | 3002076000 | 4161875000 | 4870396000 | 5129687000 | 5409483000 | 5966072000 | 6324339000 |
Insights · Dividends · Forecast · Financials · Learn